Potential role of the antioxidant N-acetylcysteine in slowing bone resorption in early post-menopausal women: a pilot study.
Sanders
Kerrie M
KM
Kotowicz
Mark A
MA
Nicholson
Geoffrey C
GC
D000111:Acetylcysteine / Q000008:administration & dosage*; D000284:Administration, Oral; D000818:Animals; D000975:Antioxidants / Q000008:administration & dosage*; D015415:Biomarkers / Q000097:blood; D001862:Bone Resorption / Q000188:drug therapy / Q000517:prevention & control*; D002118:Calcium / Q000008:administration & dosage; D002762:Cholecalciferol / Q000008:administration & dosage; D024042:Collagen Type I / Q000097:blood / Q000187:drug effects; D004311:Double-Blind Method; D005260:Female; D006801:Humans; D051379:Mice; D008875:Middle Aged; D015663:Osteoporosis, Postmenopausal / Q000188:drug therapy / Q000517:prevention & control*; D010455:Peptides / Q000097:blood / Q000187:drug effects; D010865:Pilot Projects; D017698:Postmenopause / Q000097:blood* / Q000187:drug effects
D000975:Antioxidants; D015415:Biomarkers; D024042:Collagen Type I; D010455:Peptides; C052929:collagen type I trimeric cross-linked peptide; D002762:Cholecalciferol; D002118:Calcium; D000111:Acetylcysteine